<DOC>
	<DOC>NCT03006978</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical utility, safety, and effectiveness of the TearCareâ„¢ System compared to standardized warm compress therapy for the application of controlled, localized heat therapy in adult patients with dry eye syndrome.</brief_summary>
	<brief_title>Pilot Study of the TearCare System</brief_title>
	<detailed_description />
	<criteria>Dry eye symptoms within 30 months of the screening exam with a SPEED score &gt;=6 Schirmer 1 value of &lt;010 mm in at least one eye or a Tear Breakup time &lt;10 seconds in at least one eye Any active ocular or periocular infection or inflammation Recurrent eye inflammation within the past 3 months Ocular surgery, oculoplastic surgery, ocular injury, Ocular Herpes Simplex, or Herpes Zoster Ocular surface abnormalities that may affect tear film distribution or treatment Abnormal eyelid function in either eye Diminished or abnormal facial, periocular, ocular or corneal sensation Ocular surface abnormalities such as corneal epithelial defects, ulcers, corneal dystrophies Systemic diseases resulting in dry eye (e.g. Sjogren's syndrome) Allergies to silicone tissue adhesives An absence or fibrosis of the Meibomian glands (e.g. ectodermal dysplasia). Unwillingness to abstain for the duration of the study from systemic medication known to cause ocular dryness (e.g. Accutane, antihistamines, etc.) Anyone who requires chronic use (i.e. for any portion of the study) of topical ophthalmic antibiotics, steroids, nonsteroidal antiinflammatory medications or who has been on any of these medications within the past 30 days. Unwillingness to washout and remain off certain dry eye medications for the duration of the study. Participation in another ophthalmic clinical trial within the past 30 days Coexisting conditions that could interfere with the assessment of safety or efficacy of treatment (e.g. macular disease, pregnancy, nursing, etc.)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>